Endoscopy 2011; 43(11): 950-954
DOI: 10.1055/s-0030-1256951
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Marginal ulceration after Roux-en-Y gastric bypass surgery: characteristics, risk factors, treatment, and outcomes

D. E. Azagury
Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
,
B. K. Abu Dayyeh
Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
,
I. T. Greenwalt
Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
,
C. C. Thompson
Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
› Author Affiliations
Further Information

Publication History

19 January 2011

18 May 2011

Publication Date:
13 October 2011 (online)

Background and study aims: Marginal ulcers are one of the most common complications after gastric bypass. Reported incidence varies widely (0.6–16 %) and pathogenesis is unclear. The aim of the present study was to describe characteristics, risk factors, management, and outcomes of endoscopically documented ulcers.

Patients and methods: Data from all patients diagnosed with marginal ulcers at endoscopy between 2003 and 2010 were retrospectively reviewed.

Results: A total of 103 patients with marginal ulcers presented with pain (63 %) and/or bleeding (24 %), a median of 22 months after surgery. Ulcers were located on the anastomosis (50 %) or the jejunum (40 %); sutures were visible in 35 %, and gastrogastric fistulae in 8 %. The mean pouch length was 5.6 cm. Diabetes (odds ratio [OR] 2.5; P = 0.03), smoking (OR 2.5; P = 0.02), and gastric pouch length (OR 1.2; P = 0.02) were significantly associated with marginal ulcer formation on univariate analysis; diabetes was significantly associated on multivariate analysis (OR 5.6; P = 0.003). The risk of developing a marginal ulcer decreased with time (OR 0.8; P < 0.01) and was not associated with the use of nonsteroidal anti-inflammatory drugs. At first endoscopic follow-up, 67 % of ulcers had healed. Recurrence occurred in four patients and nine patients required surgical revision.

Conclusions: The vast majority of marginal ulcers had a favorable outcome after medical treatment. However, 9 % of patients eventually required surgical revision. Therefore, endoscopic follow-up is essential. Diabetes, smoking, and long gastric pouches were significant risk factors for marginal ulcer formation, suggesting increased acid exposure and mucosal ischemia are both involved in marginal ulcer pathogenesis. Management of these factors may prove effective in managing marginal ulcers, and tailoring postoperative proton pump inhibitor therapy to patients with multiple risk factors could be effective.

 
  • References

  • 1 WHO NMH. Unhealthy diets & physical inactivity. WHO; 2009 Available at: http://www.who.int/nmh/publications/fact_sheet_diet_en.pdf [Last accessed 14 June 2011]
  • 2 Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA 2010; 303: 235-241
  • 3 Buchwald H, Oien DM. Metabolic/bariatric surgery Worldwide 2008. Obes Surg 2009; 19: 1605-1611
  • 4 Csendes A, Burgos AM, Altuve J, Bonacic S. Incidence of marginal ulcer 1 month and 1 to 2 years after gastric bypass: a prospective consecutive endoscopic evaluation of 442 patients with morbid obesity. Obes Surg 2009; 19: 135-138
  • 5 Dallal RM, Bailey LA. Ulcer disease after gastric bypass surgery. Surg Obes Relat Dis 2006; 2: 455-459
  • 6 Fox SR, Oh KH, Fox K. Vertical banded gastroplasty and distal gastric bypass as primary procedures: a comparison. Obes Surg 1996; 6: 421-425
  • 7 D’Hondt AM, Pottel H, Devriendt D et al Can a short course of prophylactic low-dose proton pump inhibitor therapy prevent stomal ulceration after laparoscopic Roux-en-Y gastric bypass?. Obes Surg 2010; 20: 595-599
  • 8 Gumbs AA, Duffy AJ, Bell RL. Incidence and management of marginal ulceration after laparoscopic Roux-Y gastric bypass. Surg Obes Relat Dis 2006; 2: 460-463
  • 9 Higa KD, Boone KB, Ho T. Complications of the laparoscopic Roux-en-Y gastric bypass: 1,040 patients – what have we learned?. Obes Surg 2000; 10: 509-513
  • 10 Jordan JH, Hocking MP, Rout WR, Woodward ER. Marginal ulcer following gastric bypass for morbid obesity. Am Surg 1991; 57: 286-288
  • 11 MacLean LD, Rhode BM, Nohr C et al Stomal ulcer after gastric bypass. J Am Coll Surg 1997; 185: 1-7
  • 12 Mason EE, Munns JR, Kealey GP et al Effect of gastric bypass on gastric secretion. Am J Surg 1976; 131: 162-168
  • 13 Patel RA, Brolin RE, Gandhi A. Revisional operations for marginal ulcer after Roux-en-Y gastric bypass. Surg Obes Relat Dis 2009; 5: 317-322
  • 14 Printen KJ, Scott D, Mason EE. Stomal ulcers after gastric bypass. Arch Surg 1980; 115: 525-527
  • 15 Rasmussen JJ, Fuller W, Ali MR. Marginal ulceration after laparoscopic gastric bypass: an analysis of predisposing factors in 260 patients. Surg Endosc 2007; 21: 1090-1094
  • 16 Sacks BC, Mattar SG, Qureshi FG et al Incidence of marginal ulcers and the use of absorbable anastomotic sutures in laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 2006; 2: 11-16
  • 17 Sanyal AJ, Sugerman HJ, Kellum JM et al Stomal complications of gastric bypass: incidence and outcome of therapy. Am J Gastroenterol 1992; 87: 1165-1169
  • 18 Sapala JA, Wood MH, Sapala MA, Flake TM Jr. Marginal ulcer after gastric bypass: a prospective 3-year study of 173 patients. Obes Surg 1998; 8: 505-516
  • 19 Wilson JA, Romagnuolo J, Byrne TK et al Predictors of endoscopic findings after Roux-en-Y gastric bypass. Am J Gastroenterol 2006; 101: 2194-2199
  • 20 Capella JF, Capella RF. Gastro-gastric fistulas and marginal ulcers in gastric bypass procedures for weight reduction. Obes Surg 1999; 9: 22-27
  • 21 Siilin H, Wanders A, Gustavsson S, Sundbom M. The proximal gastric pouch invariably contains acid-producing parietal cells in Roux-en-Y gastric bypass. Obes Surg 2005; 15: 771-777
  • 22 Felix EL, Kettelle J, Mobley E, Swartz D. Perforated marginal ulcers after laparoscopic gastric bypass. Surg Endosc 2008; 22: 2128-2132
  • 23 Pope GD, Goodney PP, Burchard KW et al Peptic ulcer/stricture after gastric bypass: a comparison of technique and acid suppression variables. Obes Surg 2002; 12: 30-33
  • 24 Ruutiainen AT, Levine MS, Williams NN. Giant jejunal ulcers after Roux-en-Y gastric bypass. Abdom Imaging 2008; 33: 575-578
  • 25 Schirmer BD, Meyers WC, Hanks JB et al Marginal ulcer. A difficult surgical problem. Ann Surg 1982; 195: 653-661
  • 26 Hedberg J, Hedenstrom H, Nilsson S et al Role of gastric acid in stomal ulcer after gastric bypass. Obes Surg 2005; 15: 1375-1378
  • 27 Spaulding L. The impact of small bowel resection on the incidence of stomal stenosis and marginal ulcer after gastric bypass. Obes Surg 1997; 7: 485-487
  • 28 Schrumpf E, Giercksky KE, Nygaard K, Fausa O. Gastrin secretion before and after gastric bypass surgery for morbid obesity. Scand J Gastroenterol 1981; 16: 721-725
  • 29 Nielsen ML, Jensen SL, Malmstrom J, Nielsen OV. Gastrin and gastric acid secretion in hepaticojejunostomy Roux-en-Y. Surg Gynecol Obstet 1980; 150: 61-64
  • 30 Doll R, Jones FA. Smoking and peptic ulcer. Schweiz Z Pathol Bakteriol 1958; 21: 309-313
  • 31 Wu WK, Cho CH. The pharmacological actions of nicotine on the gastrointestinal tract. J Pharmacol Sci 2004; 94: 348-358
  • 32 Nagata M, Okuma Y, Osumi Y. Effects of intracerebroventricularly applied nicotine on enhanced gastric acid secretion and mucosal blood flow in rats. Eur J Pharmacol 1984; 101: 185-191
  • 33 Eastwood GL. Is smoking still important in the pathogenesis of peptic ulcer disease?. J Clin Gastroenterol 1997; 25 (Suppl.1): S1-7
  • 34 Brzozowska I, Targosz A, Sliwowski Z et al Healing of chronic gastric ulcers in diabetic rats treated with native aspirin, nitric oxide (NO)-derivative of aspirin and cyclooxygenase (COX)-2 inhibitor. J Physiol Pharmacol 2004; 55: 773-790
  • 35 Yuan S, Liu Y, Zhu L. Vascular complications of diabetes mellitus. Clin Exp Pharmacol Physiol 1999; 26: 977-978
  • 36 Yang CS, Lee WJ, Wang HH et al The influence of Helicobacter pylori infection on the development of gastric ulcer in symptomatic patients after bariatric surgery. Obes Surg 2006; 16: 735-739
  • 37 Marano Jr BJ. Endoscopy after Roux-en-Y gastric bypass: a community hospital experience. Obes Surg 2005; 15: 342-345
  • 38 Papasavas PK, Gagne DJ, Donnelly PE et al Prevalence of Helicobacter pylori infection and value of preoperative testing and treatment in patients undergoing laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 2008; 4: 383-388
  • 39 Berger EH. The distribution of parietal cells in the stomach: a histotopographic study. Am J Anat 1934; 54: 87-114
  • 40 Frezza EE, Herbert H, Ford R, Wachtel MS. Endoscopic suture removal at gastrojejunal anastomosis after Roux-en-Y gastric bypass to prevent marginal ulceration. Surg Obes Relat Dis 2007; 3: 619-622
  • 41 Lee JK, Van Dam J, Morton JM et al Endoscopy is accurate, safe, and effective in the assessment and management of complications following gastric bypass surgery. Am J Gastroenterol 2009; 104: 575-582